NCT04585659 is a NA clinical trial of Qigong in Multiple Sclerosis, sponsored by National University of Natural Medicine.

Who is sponsoring NCT04585659?

NCT04585659 is sponsored by National University of Natural Medicine.

What drugs are being tested in NCT04585659?

Interventions in NCT04585659: Qigong.

What condition does NCT04585659 study?

NCT04585659 studies Multiple Sclerosis.

Is NCT04585659 still recruiting?

NCT04585659 is currently completed. Last updated 14 October 2020.

Last reviewed 2020-10-14 · How we verify

NCT04585659

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Qigong for Multiple Sclerosis: A Feasibility Study

Completed NA Last updated 14 October 2020

What this trial tests

NA trial testing Qigong in Multiple Sclerosis in 20 participants. Completed in 16 March 2018.

Timeline

1 February 2017

Primary endpoint
16 March 2018

16 March 2018

Quick facts

Lead sponsor	National University of Natural Medicine
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	supportive care
Enrollment	20
Start date	1 February 2017
Primary completion	16 March 2018
Estimated completion	16 March 2018
Sites	1 location across United States

Drugs / interventions tested

Qigong

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

National University of Natural Medicine

Who can join

18 and older, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This feasibility study explores a community-based qigong intervention for people with multiple sclerosis (MS). The primary aim is to assess the feasibility of weekly community qigong classes for people with MS. The secondary aim is to explore the effects of qigong on balance, gait, mood, fatigue, and quality of life.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Community <i>qigong</i> for People with Multiple Sclerosis: A Pragmatic Feasibility Study.
Buttolph L, Corn J, Hanes D, Bradley R, et al · · 2021 · cited 9× · PMID 33769837 · DOI 10.1089/acm.2020.0481
Participant Perspectives on Community Qigong for People with Multiple Sclerosis.
Buttolph L, Wooliscroft L, Bradley R, Zwickey H. · · 2023 · cited 1× · PMID 36895618 · DOI 10.1089/imr.2022.0079

Verify or expand the search:

Other trials of Qigong

Trials testing the same drug.

NCT06140355 — HAPPINESS: cHAnging the Perceived Pain INtEnSity in Populations With Spinal Cord Injury and With Health Disparities: A F · NA · recruiting
NCT06406283 — Active Young, Healthy Mind. The YoungFitT Project · NA · recruiting
NCT06804408 — Unpacking the "Mind" and "Body" Pathways of the Antidepressant Effect of Qigong in Older Adults: A Pilot Study · NA · completed
NCT05675995 — Qigong for Post Acute Sequelae of COVID-19 Infection · NA · completed
NCT06877325 — Synergistic Effects of Traditional Chinese Medicine Practices and Pelvic Floor Muscle Training · NA · completed

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other National University of Natural Medicine trials

Trials by the same sponsor.

NCT07498491 — Weighted Blanket Use for Adults With Chronic Pain · NA · not yet recruiting
NCT07521904 — Naturopathic Approaches to Ulcerative Colitis · not yet recruiting
NCT07151261 — Ashwagandha for Nighttime Waking · NA · active not recruiting
NCT07022275 — Safety Evaluation of THC-Free Hemp Protein Isolate · NA · active not recruiting
NCT06472791 — Centella Asiatica in Older Adults · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04585659 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National University of Natural Medicine
Last refreshed: 14 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04585659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing